Fifth Third Bancorp’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Fifth Third Bancorp's AMPH Position: Q2 2026 in Review
Fifth Third Bancorp reduced its Amphastar Pharmaceuticals (AMPH) stake by 17% in Q2 2026, selling an estimated $29.3K and leaving 7,300 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.
Fifth Third Bancorp first reported a position in AMPH in Q3 2021 and has held it in 20 quarters since. The position peaked at $171K in Q1 2026. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Fifth Third Bancorp held 7,300 shares of Amphastar Pharmaceuticals worth $147K as of Q2 2026.
- Fifth Third Bancorp sold 1,450 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $29.3K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2773 holding.
- Fifth Third Bancorp first reported a position in Amphastar Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
- Fifth Third Bancorp's Amphastar Pharmaceuticals position peaked at $171K in Q1 2026.
- 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.